American International Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

American International Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-54,410	Closed	-$955K	–	3167
2021 Q3	$955K	Sell	54,410 -401	-0.7%	-$4.68K	0.01%	1464
2021 Q2	$532	Buy	+54,811	New	+$516K	﹤0.01%	1884

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

American International Group's TRIL Position: Q4 2021 in Review

American International Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 54,410 shares — an estimated $955K sold.

American International Group first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $955K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

American International Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
American International Group sold 54,410 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $955K.
American International Group first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
American International Group's Trillium Therapeutics Inc. position peaked at $955K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on American International Group's 13F filing for Q4 2021, filed 11 Feb 2022.